IN2014DN07533A - - Google Patents

Info

Publication number
IN2014DN07533A
IN2014DN07533A IN7533DEN2014A IN2014DN07533A IN 2014DN07533 A IN2014DN07533 A IN 2014DN07533A IN 7533DEN2014 A IN7533DEN2014 A IN 7533DEN2014A IN 2014DN07533 A IN2014DN07533 A IN 2014DN07533A
Authority
IN
India
Prior art keywords
biological sample
interest
region
image
generating
Prior art date
Application number
Inventor
Antti E Seppo
Fiona Ginty
Kevin B Kenny
David Lavan Henderson
Michael J Gerdes
Moreno Adriana I Larriera
Xiaofeng Liu
Alex D Corwin
Stephen E Zingelewicz
Thomas Ha
Rjun Natalie
Ainura Kyshtoobayeve
Hewgley Denise A Hollman
Ying Li
Original Assignee
Clarient Diagnostic Services Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clarient Diagnostic Services Inc filed Critical Clarient Diagnostic Services Inc
Publication of IN2014DN07533A publication Critical patent/IN2014DN07533A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6841—In situ hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00—Image analysis
    • G06T7/0002—Inspection of images, e.g. flaw detection
    • G06T7/0012—Biomedical image inspection
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06V—IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
    • G06V20/00—Scenes; Scene-specific elements
    • G06V20/60—Type of objects
    • G06V20/69—Microscopic objects, e.g. biological cells or cellular parts
    • G06V20/695—Preprocessing, e.g. image segmentation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/10—Image acquisition modality
    • G06T2207/10064—Fluorescence image
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00—Indexing scheme for image analysis or image enhancement
    • G06T2207/30—Subject of image; Context of image processing
    • G06T2207/30004—Biomedical image processing
    • G06T2207/30096—Tumor; Lesion

Abstract

A method for generating an image of a region of interest in a biological sample comprising the steps of: generating a first image including the region of interest of the biological sample having undergone a first protocol but not a second protocol; and generating a second image including the region of interest of the biological sample after having undergone a second protocol; wherein the region of interest is smaller than said sample. Also provided is a method of analyzing a biological sample comprising providing an image of the biological sample according to the method for generating an image of a region of interest in a biological sample and analyzing the biological sample from the image. Further provided are system and kit that comprise the means for executing the novel methods.
IN7533DEN2014 2012-03-30 2013-03-21 IN2014DN07533A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261618282P 2012-03-30 2012-03-30
PCT/US2013/033286 WO2013148458A1 (en) 2012-03-30 2013-03-21 Methods for generating an image of a biological sample

Publications (1)

Publication Number Publication Date
IN2014DN07533A true IN2014DN07533A (en) 2015-04-24

Family

ID=48096230

Family Applications (1)

Application Number Title Priority Date Filing Date
IN7533DEN2014 IN2014DN07533A (en) 2012-03-30 2013-03-21

Country Status (11)

Country Link
US (1) US11573235B2 (en)
EP (1) EP2831559A1 (en)
JP (1) JP6348481B2 (en)
KR (1) KR20140145141A (en)
CN (1) CN104520689A (en)
AU (1) AU2013240137B2 (en)
CA (1) CA2867359A1 (en)
IN (1) IN2014DN07533A (en)
RU (1) RU2014137125A (en)
SG (1) SG11201406104QA (en)
WO (1) WO2013148458A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10088658B2 (en) 2013-03-18 2018-10-02 General Electric Company Referencing in multi-acquisition slide imaging
EP3108446B1 (en) 2014-02-21 2019-03-20 Ventana Medical Systems, Inc. Medical image analysis for identifying biomarker-positive tumor cells
EP3195191B1 (en) 2014-09-03 2020-10-21 Ventana Medical Systems, Inc. Systems and methods for calculating immune scores
JP6873099B2 (en) 2015-07-17 2021-05-19 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． Alignment of histopathological images
ES2921435T3 (en) * 2015-12-18 2022-08-25 Abbott Lab Methods and systems for the evaluation of histological stains
EP3203413A1 (en) * 2016-02-08 2017-08-09 Ecole Polytechnique Federale De Lausanne (Epfl) Method for quantitative measurement of a biomarker by in situ immunofluorescence and uses thereof
JP6654271B2 (en) 2016-06-10 2020-02-26 ルミネックス コーポレーション Method of integrating bright field and fluorescence channels for cell image segmentation and morphological analysis using images acquired from an imaging flow cytometer (IFC)
TWI611170B (en) * 2016-10-05 2018-01-11 閤康生物科技股份有限公司 Sample manufacturing system and manufacturing method
US9738937B1 (en) * 2017-03-31 2017-08-22 Cellmax, Ltd. Identifying candidate cells using image analysis
EP3610243A4 (en) * 2017-04-07 2020-12-16 Avelas Biosciences, Inc. Ratiometric fluorescence imaging methods
US10684199B2 (en) * 2017-07-27 2020-06-16 Agilent Technologies, Inc. Preparation of tissue sections using fluorescence-based detection
RU2717944C1 (en) * 2019-05-24 2020-03-27 Валентин Григорьевич Никитаев Method for assessing degree of malignancy of prostatic adenocarcinoma
US11525782B2 (en) * 2019-09-03 2022-12-13 Tianma Japan, Ltd. Fluorescent image analyzer
CN114463246A (en) * 2020-11-06 2022-05-10 广达电脑股份有限公司 Circle selection system and circle selection method
KR102441907B1 (en) * 2021-07-08 2022-09-08 가톨릭대학교 산학협력단 Image classification apparatus for cancer diagnosis and method for classifying image
WO2023147133A1 (en) * 2022-01-28 2023-08-03 University Of Southern California Liquid biopsy analytes to define cancer stages

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364856A (en) 1991-03-28 1994-11-15 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD]indoles
US6404906B2 (en) 1997-03-03 2002-06-11 Bacus Research Laboratories,Inc. Method and apparatus for acquiring and reconstructing magnified specimen images from a computer-controlled microscope
US7691598B2 (en) * 2001-03-30 2010-04-06 Nanoprobes, Inc. Method for detecting a target molecule by metal deposition
US7219016B2 (en) 2001-04-20 2007-05-15 Yale University Systems and methods for automated analysis of cells and tissues
US7504222B2 (en) * 2001-10-31 2009-03-17 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2004030628A2 (en) * 2002-10-02 2004-04-15 New York University Adult bone marrow derived stem cells
US20080138816A1 (en) * 2005-05-20 2008-06-12 Amnis Corporation Methods for preparing and analyzing cells having chromosomal abnormalities
US8131476B2 (en) * 2006-08-07 2012-03-06 General Electric Company System and method for co-registering multi-channel images of a tissue micro array
US8060348B2 (en) 2006-08-07 2011-11-15 General Electric Company Systems for analyzing tissue samples
DE602007008581D1 (en) 2006-08-25 2010-09-30 Cliniques Universitaires Saint METHOD FOR DETERMINING THE ANTIGEN CONTENT IN A SAMPLE THROUGH THE USE OF AN IMMUNOHISTOCHEMICAL DOUBLE DETECTION
US8019134B2 (en) * 2006-11-16 2011-09-13 Definiens Ag Automatic image analysis and quantification for fluorescence in situ hybridization
US7629125B2 (en) * 2006-11-16 2009-12-08 General Electric Company Sequential analysis of biological samples
US7741045B2 (en) 2006-11-16 2010-06-22 General Electric Company Sequential analysis of biological samples
EP2068618A4 (en) * 2007-05-21 2011-01-19 Dana Farber Cancer Inst Inc Compositions and methods for cancer gene discovery
WO2008148546A2 (en) * 2007-06-06 2008-12-11 F.Hoffmann-La Roche Ag Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a nir fluorescence label
US20090258365A1 (en) * 2008-03-25 2009-10-15 Terstappen Leon W M M METHOD FOR DETECTING IGF1R/Chr 15 in CIRCULATING TUMOR CELLS USING FISH
US20110189670A1 (en) * 2008-07-07 2011-08-04 Ruth L Katz Circulating Tumor and Tumor Stem Cell Detection Using Genomic Specific Probes
JP5551702B2 (en) 2008-09-16 2014-07-16 ヒストロックス，インコーポレイテッド． Reproducible quantification of biomarker expression
US8269827B2 (en) * 2009-09-29 2012-09-18 General Electric Company System and methods for mapping fluorescent images into a bright field color space
US8639013B2 (en) 2011-08-17 2014-01-28 General Electric Company System and methods for generating a brightfield image using fluorescent images
US8568991B2 (en) 2011-12-23 2013-10-29 General Electric Company Photoactivated chemical bleaching of dyes

Also Published As

Publication number Publication date
WO2013148458A1 (en) 2013-10-03
KR20140145141A (en) 2014-12-22
EP2831559A1 (en) 2015-02-04
US11573235B2 (en) 2023-02-07
SG11201406104QA (en) 2014-10-30
AU2013240137A1 (en) 2014-10-02
RU2014137125A (en) 2016-05-27
JP2015514213A (en) 2015-05-18
JP6348481B2 (en) 2018-06-27
CN104520689A (en) 2015-04-15
US20150050650A1 (en) 2015-02-19
CA2867359A1 (en) 2013-10-03
AU2013240137B2 (en) 2017-04-20

Similar Documents

Publication Publication Date Title
IN2014DN07533A (en)
IN2014DN07531A (en)
HK1201180A1 (en) Method and system for analyzing biological specimens by spectral imaging
HK1215890A1 (en) System and method for reviewing and analyzing cytological specimens
MY182625A (en) Bispecific format suitable for use in high-through-put screening
MX362545B (en) Image analysis and measurement of biological samples.
HK1196984A1 (en) Laboratory sample distribution system, laboratory system and method of operating
MX341922B (en) Methods for data collection and distribution.
WO2012155072A3 (en) Isolation of nucleic acids
IN2014DN08017A (en)
IN2014DN08573A (en)
GB2497700A (en) Compact microscopy system and method
HK1221051A1 (en) Method and system for analyzing biological specimens by spectral imaging
SG11201601031QA (en) Method for preparing peptide fragments, kit for preparing peptide fragments to be used therein, and analysis method
GB201309564D0 (en) Image processing apparatus, image processing method, and program
MX2014014763A (en) Image processing method and apparatus.
NZ702867A (en) Systems and methods for processing and imaging of biological samples
EP2705134A4 (en) White blood cell analysis system and method
MX2019012139A (en) Preparation of 18f-fluciclovine.
EP2993469A4 (en) Method for analysis of sample and apparatus therefor
GB2496246B (en) Method and apparatus for identifying regions of interest in medical imaging data
EP2902965A4 (en) Heteroptics analysis device, heteroptically-altered image generating device for generating heteroptics to create perception approximating original image, heteroptics analysis method, method for generating heteroptically-altered image to create perception approximating original image, and program
EP2799845A4 (en) System for provision of analysis results, analysis terminal, and method for provision of analysis results
WO2014091069A3 (en) Method and apparatus for augmenting an image of a location with a representation of a transient object
IN2014CN02937A (en)